info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Infusion Systems Companies

Infusion system companies specialize in the development, manufacturing, and distribution of medical devices and equipment used for the controlled delivery of fluids, medications, and nutrients into a patient's body. These systems are commonly used in healthcare settings, such as hospitals and clinics, to administer intravenous (IV) fluids, medications, and other treatments.

Infusion System Key Companies*Disclaimer: List of key companies in no particular orderLatest Infusion system Companies Update



  • Feb 2023: In partnership with Siemens Healthineers, Terumo India, the Indian branch of the Japan-based Terumo Corporation, has launched a first-of-its-kind program for Cathlab Directors that aims to raise standards of care and improve productivity in Cathlabs throughout India. The program is being carried out with Executive Education at the Indian School of Business (ISB ExecEd), one of the world's top business schools. The intensifying incidence of cardiovascular diseases and the technological breakthroughs in medical care drive entrepreneurship in India's healthcare delivery. This is demonstrated by the quick expansion of Cathlabs, which sees the establishment of 200–250 additional labs annually.




  • Sep 2023: The biosimilar of Actemra/RoActemra (tocilizumab) developed by Fresenius Kabi has been given marketing permission by the European Commission (EC). With the approval of both the subcutaneous and intravenous versions, Tyenne, a biologic manufactured by Roche, is the first to be approved by the European Commission. Before, AbbVie's Humira (adalimumab) biosimilar, called Idacio, and Amgen's Neulasta (pegfilgrastrim) copycat, called Stimufend, were approved in Europe by Fresenius Kabi. The business launched its first copycat biologic in the USA this year and is working on further autoimmune and oncology biosimilars. Both are in the late stages of research.


List of Infusion system Key companies in the market

  •  Becton

  •  Dickinson and Company (US)

  •  B. Braun Melsungen AG (Germany)

  •  Baxter International Inc. (US)

  •  Fresenius Kabi (Germany)

  •  ICU Medical, Inc. (US)

  •  Medtronic plc (Ireland), Moog Inc. (US)

  •  Smiths Medical (US)

  •  Terumo Corporation (Japan)

  •  NIPRO Corporation (Japan)

  •  Avanos Medical, Inc. (US)

  •  Tandem Diabetes Care, Inc. (US)

  •  JMS Co., Ltd. (Japan)

  •  Insulet Corporation (US)

  •  Roche Diagnostics (Switzerland)

  •  Zyno Medical (US)

  •  Teleflex, Inc. (US)

  •  Mindray Medical International Limited (China)

  •  Micrel Medical Devices SA (Greece)

  •  Ypsomed Holding AG (Switzerland)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.